In Brief This Week: Roche NimbleGen; Life Technologies; PerkinElmer; Luminex; CLC bio; Diffinity Genomics; Vela Diagnostics; Bayer CropScience | GenomeWeb

NEW YORK (GenomeWeb News) – Roche will shutter its NimbleGen microarray business, and will phase out array production and services by the end of the year. At the same time, the firm will continue to provide target enrichment products for use with next-generation sequencing, a spokesperson told GenomeWeb Daily News sister publication BioArray News this week.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new single-cell RNA sequencing technique to study proliferating cells, and more.

South African researchers uncover bone cancer in an ancient hominin ancestor.

English bulldogs suffer from low genetic diversity and might have to be outbred to improve their health, according to a new study.

Theresa May tries to reassure researchers about the UK's commitment to science, New Scientist reports.